Sign in
Enrolling by invitationNo phase

Comparing current treatments for children with Legg-Calvé-Perthes disease, a hip disorder

Compares results of usual treatments in children with Legg-Calvé-Perthes disease.

Key facts

Who runs it
Texas Scottish Rite Hospital for Children
Where
Atlanta, Aurora, Baltimore, Birmingham, Boston, Charlotte, Chicago, Cincinnati, Columbus, Dallas, Germantown, Hartford, Houston, Los Angeles, New York, Oklahoma City, Philadelphia, Portland, Rochester, Saint Paul, San Diego, San Francisco, Seattle, The Bronx, Washington D.C., and Wilmington, United StatesSee the 28 sitesAlso in 14 other countries, 18 sites
Trial code
Registry title
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
Status
Enrolling by invitation
People taking part
1,500 people, planned
Started
Aug 2012
Expected to end
Sept 2032
Type of study
Observational, 12 groups
Treatments tested
  • Osteotomy + Long Term Non-Weight Bearing
  • Osteotomy + Short Term Non-Weight Bearing
  • Nonoperative Observation
  • Multiple Epiphyseal Drilling
Record updated
6 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and teens with Legg-Calvé-Perthes disease, a childhood hip disorder. It follows the results of the usual treatments chosen by their doctors.

Age
1 to 18 years
Sex
All sexes
Disease stage
Diagnosed with Legg-Calvé-Perthes disease. People over age 11 with possible bone death in the thigh bone head (femoral osteonecrosis) caused by injury or corticosteroid therapy can also join.
Earlier treatment
No previous surgery on the affected hip.

Main reasons for not taking part

  • Previous surgery on the affected hip

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Diagnosed with Legg-Calvé-Perthes disease
  • Between age 1-18
  • Patients with possible secondary femoral osteonecrosis if over the age of 11 due to trauma or corticosteroid therapy are also eligible

Who cannot take part

  • Patients with previous surgical treatment on the affected hip

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 1 and 18 years old?

Where in United States

Also in 14 other countries, 18 sites

  • Children's Orthopaedics of AtlantaAtlanta, United StatesEnrolling by invitation
  • Children's Hospital ColoradoAurora, United StatesEnrolling by invitation
  • Johns HopkinsBaltimore, United StatesEnrolling by invitation
  • Children's Hospital of AlabamaBirmingham, United StatesEnrolling by invitation
  • Children's Hospital, BostonBoston, United StatesEnrolling by invitation
  • OrthoCarolinaCharlotte, United StatesEnrolling by invitation
  • Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, United StatesEnrolling by invitation
  • Cincinnati Children's Hospital Medical CenterCincinnati, United StatesEnrolling by invitation
  • Nationwide Children's HospitalColumbus, United StatesEnrolling by invitation
  • Texas Scottish Rite Hospital for ChildrenDallas, United StatesEnrolling by invitation
  • University of Tennessee-Campbell ClinicGermantown, United StatesEnrolling by invitation
  • Connecticut Children's Medical CenterHartford, United StatesEnrolling by invitation
  • Texas Children's HospitalHouston, United StatesEnrolling by invitation
  • Children's Hospital of Los AngelesLos Angeles, United StatesEnrolling by invitation
  • Kaiser Permanente HospitalLos Angeles, United StatesEnrolling by invitation
  • New York Presbyterian Hospital (Columbia Campus)New York, United StatesEnrolling by invitation
  • NYU Langone/Hospital for Joint DiseaseNew York, United StatesEnrolling by invitation
  • Oklahoma University Health Science CenterOklahoma City, United StatesEnrolling by invitation
  • Children's Hospital of PhiladelphiaPhiladelphia, United StatesEnrolling by invitation
  • Oregon Health and Science UniversityPortland, United StatesEnrolling by invitation
  • Mayo ClinicRochester, United StatesEnrolling by invitation
  • Gillette Children's Specialty HealthcareSaint Paul, United StatesEnrolling by invitation
  • Rady Children's Hospital CaliforniaSan Diego, United StatesEnrolling by invitation
  • UCSF Benioff Children's HospitalsSan Francisco, United StatesEnrolling by invitation
  • Seattle Children's HospitalSeattle, United StatesEnrolling by invitation
  • Children's Hospital at MontefioreThe Bronx, United StatesEnrolling by invitation
  • Children's National Medical CenterWashington D.C., United StatesEnrolling by invitation
  • Alfred I. DuPont Hospital for Children of the Nemours FoundationWilmington, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Legg-Calvé-Perthes disease is a childhood hip disorder which is common enough to be a significant public health problem (affects 1 in 740 boys between ages 0-14), but uncommon enough to have a sufficient number of patients from a single institution to perform a definitive prospective study comparing the results of current treatments. The present study will establish a database of prospectively identified patients with Legg-Calvé-Perthes (LCP) Disease and collect information regarding their presentation, treatment, and outcomes in the course of receiving currently available treatments.

Read full original descriptionShow less

This study seeks to compare the outcomes of current treatments in the management of different age groups (ages 1-6, 6-8, 8-11, >11) of patients with Perthes disease at two- and five-year followup and at skeletal maturity. For each age group, two to three common treatment regimens currently used by practicing pediatric orthopaedic surgeons will be compared. The intervention a patient receives is determined through physician treatment expertise, and is not pre-determined by the study.

The 12 groups in the trial

  • Nonoperative management between ages 6-8 in early stage

    The choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Treatment: Nonoperative Observation

  • Operative management between age 6-8 in early stage

    Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty) rendered in the early stage of the disease process

    Treatment: Osteotomy + Long Term Non-Weight Bearing and Osteotomy + Short Term Non-Weight Bearing

  • Nonoperative management between age 8-11 in early stage

    Patients who do not undergo some form of containment surgery because of medical, social, or other reasons will receive no surgical treatment.

    Treatment: Nonoperative Observation

  • Operative containment with short-term non-weightbearing in early stage

    As per the current standard practice for patients between age 8-11 in developed countries, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better "contain" the femoral head underneath the acetabulum. Post-operative treatment will include 6 weeks of non-weight bearing on the operated leg.

    Treatment: Osteotomy + Short Term Non-Weight Bearing

  • Operative containment with prolonged non-weightbearing in early stage

    As per the current standard practice for patients between age 8-11, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better "contain" the femoral head underneath the acetabulum. Post-operative treatment will include 6 months of non-weight bearing on the operated leg.

    Treatment: Osteotomy + Long Term Non-Weight Bearing

  • Operative containment for over 11 age group

    Patients presenting over age 11 may receive multiple drilling and be non weight bearing for up to 6 months according to the treating physician's preference. Patients with application of fixator (arthrodiastasis) will be studied in this cohort arm as well, which typically involved 3-4 months followed by 8-12 weeks of non-weight bearing after fixator removal. Other surgical techniques may be included, however these are the most common for this age group.

    Treatment: Osteotomy + Long Term Non-Weight Bearing, Osteotomy + Short Term Non-Weight Bearing, and Multiple Epiphyseal Drilling

  • Nonoperative management in over 11 age group

    Patients will be non-weight bearing and receive physical therapy according to the physician preferences.

    Treatment: Nonoperative Observation

  • Nonoperative management in 1-6 age group

    The choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Treatment: Nonoperative Observation

  • Operative management in 1-6 age group

    The choice of osteotomy management with containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Treatment: Osteotomy + Long Term Non-Weight Bearing, Osteotomy + Short Term Non-Weight Bearing, and Multiple Epiphyseal Drilling

  • Late Stage Bracing group

    Patients presenting with \<= 20 degrees of abduction on a maximum abduction x-ray treated with bracing who also present in the late stages of the disease (Waldenstrom Stage IIb or IIIa).The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Treatment: Nonoperative Observation

  • Late Stage Symptomatic treatment group

    Patients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated symptomatically. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Treatment: Nonoperative Observation

  • Late Stage Surgical Containment group

    Patients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated with surgical containment. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Treatment: Osteotomy + Long Term Non-Weight Bearing, Osteotomy + Short Term Non-Weight Bearing, and Multiple Epiphyseal Drilling

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
Plain-language title
Comparing current treatments for children with Legg-Calvé-Perthes disease, a hip disorderGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT02040714, who can take part
Record updated
6 May 2025